Clinical trial
A Randomized, Double-blind, Placebo-controlled Clinical Study to Evaluate Mavacamten in Adults With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy
NCT05582395 is registered in ClinicalTrials.gov with Bristol-Myers Squibb as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-blind, Placebo-controlled Clinical Study to Evaluate Mavacamten in Adults With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy
- Lead sponsor
- Bristol-Myers Squibb
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- December 14, 2022
- Completion date
- October 20, 2025
- Enrollment
- 580 (actual)
- Sites
- 224
Conditions
As the registry lists them; a condition with its own page is linked.